← back to search

Xiaoqing Xi

Nanchang University · CN
🔎 Find collaborators in Materials Chemistry · Ceramics and Composites →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Materials Chemistry · Ceramics and Composites
Research interest
Research focused on Pioglitazone and Autophagy, with related work in Kidney, Gene knockdown, AMPK. Notable publications include 'MicroRNA-21 Attenuates Renal Ischemia Reperfusion Injury via Targeting Caspase Signaling in Mice', 'Pioglitazone protects tubular cells against hypoxia/reoxygenation injury through enhancing autophagy via AMPK-mTOR signaling pathway', and 'Pioglitazone protects against renal ischemia-reperfusion injury by enhancing antioxidant capacity'.
h-index
citations
481
works
19
NIH funding
primary concept
email

Recent publications

Constructing a machine learning model for systemic infection after kidney stone surgery based on CT values
Scientific Reports 2025cited by 9position: middledoi
Pioglitazone ameliorates ischemia/reperfusion-induced acute kidney injury via oxidative stress attenuation and NLRP3 inflammasome
Human Cell 2024cited by 10position: lastdoi
Electrospun nanoscale bent fibrous membrane with controllable porous structure and hydrophilic modification for high-efficiency oil-water separation, particle/bacterial filtration and antibacterial applications
Journal of Membrane Science 2023cited by 25position: lastdoi
TUBA1C is a potential new prognostic biomarker and promotes bladder urothelial carcinoma progression by regulating the cell cycle
BMC Cancer 2023cited by 9position: lastdoi
Identification of differentially expressed circRNAs in prostate cancer of different clinical stages by RNA sequencing
Scientific Reports 2023cited by 6position: middledoi
Identification of cuproptosis-related long noncoding RNA signature for predicting prognosis and immunotherapy response in bladder cancer
Scientific Reports 2022cited by 9position: lastdoi
New Prognostic Gene Signature and Immune Escape Mechanisms of Bladder Cancer
Frontiers in Cell and Developmental Biology 2022cited by 8position: lastdoi
Gender Differential Expression of AR/miR-21 Signaling Axis and Its Protective Effect on Renal Ischemia-Reperfusion Injury
Frontiers in Cell and Developmental Biology 2022cited by 6position: lastdoi
ACSL3 is a potential prognostic biomarker for immune infiltration in clear cell renal cell carcinoma
Frontiers in Surgery 2022cited by 5position: lastdoi
Pioglitazone Ameliorates Renal Ischemia-Reperfusion Injury via Inhibition of NF-κB Activation and Inflammation in Rats
Frontiers in Physiology 2021cited by 38position: middledoi
Pioglitazone protects tubular cells against hypoxia/reoxygenation injury through enhancing autophagy via AMPK-mTOR signaling pathway
European Journal of Pharmacology 2019cited by 46position: firstdoi
Pioglitazone Protects Against Renal Ischemia-Reperfusion Injury via the AMP-Activated Protein Kinase-Regulated Autophagy Pathway
Frontiers in Pharmacology 2018cited by 44position: middledoi
Inhibition of NEDD4 inhibits cell growth and invasion and induces cell apoptosis in bladder cancer cells
Cell Cycle 2017cited by 39position: middledoi
Ubiquitin-like protein FAT10 promotes bladder cancer progression by stabilizing survivin
Oncotarget 2016cited by 39position: middledoi
Rock2 promotes RCC proliferation by decreasing SCARA5 expression through β-catenin/TCF4 signaling
Biochemical and Biophysical Research Communications 2016cited by 34position: middledoi
MicroRNA-21 Attenuates Renal Ischemia Reperfusion Injury via Targeting Caspase Signaling in Mice
American Journal of Nephrology 2014cited by 61position: middledoi
Pioglitazone protects against renal ischemia-reperfusion injury by enhancing antioxidant capacity
Journal of Surgical Research 2013cited by 45position: middledoi
Protective effects of pioglitazone on renal ischemia-reperfusion injury in mice
Journal of Surgical Research 2012cited by 30position: middledoi
Giant Adrenal Angiomyolipoma
The Journal of Clinical Endocrinology & Metabolism 2012cited by 18position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Honglin Hu · Nanchang University8 papers (2012–2024)Zhenfeng Ye · Nanchang University7 papers (2014–2025)Yawei Huang · Nanchang University6 papers (2018–2025)Gaomin Huang · Nanchang University6 papers (2022–2024)Cong Zou · Nanchang University5 papers (2012–2019)Chiyu Zhang · Fudan University3 papers (2022–2023)Gongxian Wang · Nanchang University2 papers (2012–2013)Jianghua Shao · Nanchang University2 papers (2016–2016)Xiuxia Liu · Shandong University2 papers (2016–2016)Renrui Kuang · Nanchang University2 papers (2017–2018)Xueming Huang · Nanchang University2 papers (2012–2013)Ruizhen Huang · Nanchang University2 papers (2021–2022)Leifeng Chen · Nanchang University2 papers (2016–2016)Chiyu Zhang · Nanchang University2 papers (2022–2022)Honglin Hu · Nanchang University2 papers (2022–2023)Jiaxin Li · Guangzhou University of Chinese Medicine1 papers (2025–2025)Jing Zhang · Nanjing Agricultural University1 papers (2024–2024)Yi Jiang · Nanchang University1 papers (2022–2022)Jianhua Xiong · Nanchang University1 papers (2017–2017)Xing Wang · Nanchang University1 papers (2023–2023)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Materials Chemistry · Ceramics and Composites →